Monthly Archives: January 2018

Related StoriesPacemakers can detect AF and enable initiation of anticoagulation for stroke preventionMore study needed before recommending antidepressants, Alzheimer's disease medicines for stroke recovery: StudyMeta-analysis backs thrombectomy more than regular stroke careIn the current study, the research group obtained mortality and cause-of-death data for 100 % of the individuals through December of 2006. Using traditional along with novel statistical methods, the experts determined that the length in time that patients survived without encountering a cardiovascular-related death was significantly much longer for the group that received chlorthalidone treatment – around one day for every month of antihypertensive treatment. Because of the average age group of the trial group and the importance of competing factors behind death, such as cancer, in that group, the researchers analyzed in life expectancy for all-cause mortality also, which resulted in a gain of one-half day time for every month of antihypertensive treatment in the treatment group over the placebo group. Continue reading

New regions of research will be reviewed within the next five main themes of the congress: Cell biology, biochemistry and physiology; Environment, interactions and ecology; Evolution, systematics and biodiversity; Fungal pathogenesis and disease control; Genomics, genetics and molecular biology. Nick Browse, Professor of Fungal Cell Biology at the University of Seat and Edinburgh of IMC9, is looking forward to the culmination of years of preparing, ‘The UK has a long tradition to be at the forefront of worldwide mycology and we are remarkably pleased to welcome more than 1700 delegates from around the world to listen to from an eminent fall into line of plenary speakers also to enjoy a far reaching programme. Continue reading

John Langstaff, Cangene’s president and CEO. With an elevated strategic focus on our commercial products, this European acceptance complements our attempts in the United States where we are building our sales team to strengthen our market placement. Cangene manufactures its Hepatitis B Immune Globulin in its Winnipeg service utilizing a process similar to that of WinRho SDF, Vaccinia Immune Globulin and VariZIG, the Company’s other hyperimmune products that have been approved in the usa and/or Canada.. Continue reading

Page 3 of 3123